» Articles » PMID: 29955537

Assessment of Pharmacists' Self-reported Preparedness to Provide Pharmacotherapy Services to Individuals with Psychiatric Disorders

Overview
Specialty Psychiatry
Date 2018 Jun 30
PMID 29955537
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The purpose of this study was to compare pharmacists' level of training and/or experience in psychiatric pharmacy to (1) their self-perceived preparedness to provide pharmacotherapy services to individuals with psychiatric disorders and (2) barriers to providing pharmacotherapy services to individuals with psychiatric disorders.

Methods: This study used data from an Internet-based questionnaire. Respondents were divided into 2 groups: group A completed the Arizona Pharmacy Association's Psychiatric Certificate Program, and/or was board certified in psychiatric pharmacy, and/or was a member of the College of Psychiatric and Neurologic Pharmacists, and/or had completed a psychiatric pharmacy residency; group B had no specialized training and/or experience in psychiatric pharmacy. A Mann-Whitney test was used to compare the scaled responses for each group.

Results: Compared with pharmacists without training and/or experience in psychiatry (N = 235), respondents with specialized training and/or experience in psychiatric pharmacy (N = 38) reported more frequent interactions with patients with psychiatric disorders and provided more counseling and drug information, monitoring for adverse drug reactions, screening for treatment issues, and both pharmacologic and nonpharmacologic treatment recommendations ( < .05). Pharmacists trained in psychiatry reported being more prepared to provide all pharmacotherapy services ( < .003), except in addressing nonadherence, utilizing online resources, and providing pharmacotherapy services to patients with attention deficit hyperactivity disorder. They reported fewer barriers to providing pharmacotherapy services ( < .005), except for time to provide services, having a private consultation area, and reimbursement for patient care activities.

Discussion: This study found that responding pharmacists without psychiatric training/experience may need additional education and training after graduation and that they perceive more barriers in providing services to the population with psychiatric disorders.

Citing Articles

Impact of an Educational Intervention on Hospital Pharmacists' Knowledge and Application of Substance Withdrawal Management.

Brust-Sisti L, Khieu T, Plotkin S, Sturgill M, Moreau S Subst Abuse. 2023; 17:11782218231206119.

PMID: 37920806 PMC: 10619356. DOI: 10.1177/11782218231206119.


Knowledge, attitude, and readiness of pharmacists toward medication therapy management for patients with attention deficit hyperactivity disorder: a cross-sectional quantitative study.

Al-Dujaili Z, Hallit S, Al Faraj A Int J Clin Pharm. 2023; 45(5):1277-1285.

PMID: 37695404 DOI: 10.1007/s11096-023-01628-3.


Comprehensive Medication Management Services with a Holistic Point of View, a Scoping Review.

Rojas E, Dupotey N, De Loof H Pharmacy (Basel). 2023; 11(1).

PMID: 36827675 PMC: 9964776. DOI: 10.3390/pharmacy11010037.


Pharmacists' knowledge, experiences and perceptions of treatments for attention-deficit/hyperactivity disorder.

Yuen T, Zhang H, Bonin R Can Pharm J (Ott). 2021; 154(2):110-119.

PMID: 33868522 PMC: 8020279. DOI: 10.1177/1715163520981397.


Pharmacists' acceptability of a men's mental health promotion program using the Theoretical Framework of Acceptability.

Murphy A, Gardner D AIMS Public Health. 2019; 6(2):195-208.

PMID: 31297404 PMC: 6606526. DOI: 10.3934/publichealth.2019.2.195.

References
1.
Cates M, Burton A, Woolley T . Attitudes of pharmacists toward mental illness and providing pharmaceutical care to the mentally ill. Ann Pharmacother. 2005; 39(9):1450-5. DOI: 10.1345/aph.1G009. View

2.
Rickles N, Dube G, McCarter A, Olshan J . Relationship between attitudes toward mental illness and provision of pharmacy services. J Am Pharm Assoc (2003). 2010; 50(6):704-13. DOI: 10.1331/JAPhA.2010.09042. View

3.
Phokeo V, Sproule B, Raman-Wilms L . Community pharmacists' attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv. 2004; 55(12):1434-6. DOI: 10.1176/appi.ps.55.12.1434. View

4.
Scheerder G, De Coster I, Van Audenhove C . Pharmacists' role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008; 59(10):1155-60. DOI: 10.1176/ps.2008.59.10.1155. View